Aspirin and calcium as a preventive therapy of early and late preeclampsia

  • A. O. Piskun
Keywords: preventive therapy, preeclampsia, aspirin, calcium.

Abstract

Annotation. Preeclampsia and fetal growth restriction are major causes of perinatal death and handicap in survivors. Indications for aspirin during pregnancy are a matter of debate. The optimum dosage, from 75mg/day to 150mg/day, needs to be determined. The aim of the research was to estimate the impact of low-dose aspirin and calcium on prevention of preeclampsia. During the research there was conducted a prospective analysis of the effectiveness of aspirin and calcium in pregnant women with preeclampsia from VMCM hospital №1, in a period from 2016 till 2018. 88 women participated, they were divided into two investigated groups: I – 36 women with early preeclampsia (EP), and II group – 52 women with late preeclampsia (LP). In EP group 28 women were taking aspirin in dose of 75 mg, in LP – 36. Also, in EP group 12 women were taking low doses of calcium (˂1g/day), and 26 in LP group (tab. 1). Main diagnostically significant indexes were determined, which later underwent comparative analysis for all groups. Statistical processing of the obtained results was performed by odds ratio, its standard error and 95% confidence interval were calculated according to Altman, 1991. We didn’t define significant preventive differences in preeclampsia phenotype compared subgroups. Aspirin in dose of 75 mg/day and Calcium ˂1g/day is ineffective, also taking to account irregular intake – for 4-5-6 times per week. Preventive therapy requires definite period of beginning – 12 weeks of gestation and systemic everyday intake of drugs. In future, we need to explore a perfect dose of aspirin and calcium supplementation to prevent preeclampsia and hypertensive disorders in pregnancy.

Downloads

Download data is not yet available.

References

[1] Abbasalizadeh, S., Abam, F., Mirghafourvand, M., Abbasalizadeh, F., Taghavi, S., & Hajizadeh, K. (2020). Comparing levels of vitamin D, calcium and phosphorus in normotensive pregnant women and pregnant women with preeclampsia. J Obstet Gynaecol., 40(8), 1069-1073. doi: 10.1080/01443615.2019.1678575
[2] Atallah, A., Lecarpentier, E., Goffinet, F. Doret-Dion, M., Gaucherand, P., Tsatsaris, V. (2017). Aspirin for Prevention of Preeclampsia. Drugs, 77(17), 1819-1831. doi: 10.1007/s40265-017-0823-0
[3] Atallah, A., Lecarpentier, E., Goffinet, F., Gaucherand, P., Doret-Dion, M., & Tsatsaris V. (2019). Aspirin and preeclampsia. Presse Med., 48(1/1), 34-45. doi: 10.1016/j.lpm.2018.11.022
[4] Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., … & Wong, J. B. (2021). Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: US Preventive Services Task Force Recommendation Statement. JAMA, 326(12), 1186-1191. doi: 10.1001/jama.2021.14781
[5] Gatford, K. L., Andraweera, P. H., Roberts, C. T., & Care, A. S. (2020). Animal Models of Preeclampsia. Causes, Consequences, and Interventions. Hypertension, 75(6), 1363-1381. DOI: 10.1161/HYPERTENSIONAHA.119.14598
[6] Hofmeyr, G. J., Betrán, A. P., Singata-Madliki, M., Cormick, G., Munjanja, S. P., Fawcus, S., … & Belizán, J. M. (2019). Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet, 393(10169), 330-339. doi: 10.1016/S0140-6736(18)31818-X
[7] Khaing, W., Arj-Ong Vallibhakara, S., Tantrakul, V., Vallibhakara, O., Rattanasiri, S., McEvoy, M., … & Thakkinstian, A. (2017). Calcium and Vitamin D Supplementation for Prevention of Preeclampsia: A Systematic Review and Network Meta-Analysis. Nutrients, 9(10), 1141. doi: 10.3390/nu9101141
[8] Loussert, L., Vidal, F., Parant, O., Hamdi, S. M., Vayssiere, C., & Guerby, P. (2020). Aspirin for prevention of preeclampsia and fetal growth restriction. Prenat Diagn., 40(5), 519-527. doi: 10.1002/pd.5645
[9] Murashko, A. V., Fayzullin, A. L., & Murashko L. E. (2015). Ангиогенные факторы роста в патогенезе преэклампсии [Angiogenic growth factors in the pathogenesis of preeclampsia]. Архив акушерства и гинекологии им. В. Ф. Снегирева – V. F. Snegirev Archive of Obstetrics and Gynecology, 2(3), 4-7.
[10] Roberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N., & Bujold, E. (2017). The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis. Am J Obstet Gynecol., 216(2), 110-120.e6. doi: 10.1016/j.ajog.2016.09.076
[11] Rolnik, D. L., Wright, D., Poon, L. C., O'Gorman, N., Syngelaki, A., Matallana, C. de Paco, … & Nicolaides, K. H. (2017). Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med., 377(7), 613-622. doi: 10.1056/NEJMoa1704559
[12] Sun, X., Li, H., He, X., Li, M., Yan, P., Xun, Y., … & Zhang, X. (2019). The association between calcium supplement and preeclampsia and gestational hypertension: a systematic review and meta-analysis of randomized trials. Hypertens Pregnancy, 38(2), 129-139. doi: 10.1080/10641955.2019.1593445
[13] Ting-ting Xu Fan Zhou, Chun-yan Deng, Gui-qiong Huang, Jin-ke Li, Xiao-dong Wang. (2015). Low-Dose Aspirin for Preventing Preeclampsia and Its Complications: A Meta-Analysis. J Clin Hypertens (Greenwich), 17(7), 567-73. doi: 10.1111/jch.12541
[14] Van Doorn, R., Mukhtarova, N., Flyke, I. P., Lasarev, M., Kim, KM., Hennekens, C. H., & Hoppe, K. K. (2021). Dose of aspirin to prevent preterm preeclampsia in women with moderate or high-risk factors: A systematic review and meta-analysis. PLoS One, 16(3), e0247782. doi: 10.1371/journal.pone.0247782
Published
2022-03-28
How to Cite
Piskun, A. O. (2022). Aspirin and calcium as a preventive therapy of early and late preeclampsia. Reports of Vinnytsia National Medical University, 26(1), 82-85. https://doi.org/10.31393/reports-vnmedical-2022-26(1)-15